MedPath

Comparing success rate of three antibiotic regimes based on furazolidone, clarithromycine and levofluxacin in patients with gastric infectio

Phase 2
Conditions
Helicobacter pylori.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT2016040318124N4
Lead Sponsor
Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients aged 15 to 80 years; patients with dyspepsia and Peptic ulcer disease; Patients undergoing upper endoscopic procedure with positive rapid urease test (RUT).
Exclusion criteria: gastrointestinal bleeding; Patients with history of taking antibiotic in last 3 weeks; taking PPI or H2 receptor antagonists in the last two week; gastric cancer; suffering from any disease needing to consume another antibiotic

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori eradication. Timepoint: 2 week after treatment. Method of measurement: Stool antigen test.
Secondary Outcome Measures
NameTimeMethod
Drug reaction. Timepoint: During treatment. Method of measurement: Questioner.
© Copyright 2025. All Rights Reserved by MedPath